Neuroscience is the Next Oncology

by Michael D. Ehlers, MD, PhD Dr. Ehlers is with Biogen in Cambridge, Massachusetts. Innov Clin Neurosci. 2018;15(3–4):15–16 Funding: No funding was received for the preparation of this article. Disclosures: Dr. Ehlers is an employee and shareholder at Biogen Inc. in Cambridge, Massachusetts. Prominent and expensive failures in Alzheimer’s disease therapies have led to a contagious belief system in some parts of the biopharma industry that neuroscience is just too hard, too risky, and too uncertain. But, might this belief system itself be a residual bias of the past? Close inspection reveals all the signs of a coming era of neurotherapeutics. Regardless of therapeutic area, drug discovery and development is a long, difficult, and failure-ridden journey. Even in those areas where success blossoms—most recently in immuno-oncology­—it is easy to forget that the landscape once looked different to the casual observer. Indeed, just a few years ago many biopharmaceutical companies eschewed immuno-oncology as a marginal area with limited potential for clinical impact. Hindsight is 20-20, but a look into the rear view mirror identifies the signs and signals that foretold the advent of the new wave of immuno-oncology therapeutics. Starting with the identification of central molecular pathways for lymphocyte activation or suppression, more detailed understanding of the tumor microenvironment, the development of targeted checkpoint inhibitors, and ident...
Source: Innovations in Clinical Neuroscience - Category: Neuroscience Authors: Tags: Commentary Current Issue Source Type: research

Related Links:

Publication date: Available online 14 October 2019Source: The Lancet Respiratory MedicineAuthor(s): Jane S Lucas, Stephanie D Davis, Heymut Omran, Amelia ShoemarkSummaryPrimary ciliary dyskinesia is a genetically and clinically heterogeneous syndrome. Impaired function of motile cilia causes failure of mucociliary clearance. Patients typically present with neonatal respiratory distress of unknown cause and then continue to have a daily wet cough, recurrent chest infections, perennial rhinosinusitis, otitis media with effusion, and bronchiectasis. Approximately 50% of patients have situs inversus, and infertility is common....
Source: The Lancet Respiratory Medicine - Category: Respiratory Medicine Source Type: research
Authors: Husain AM Abstract [Box: see text]. PMID: 31608668 [PubMed - as supplied by publisher]
Source: Epilepsy Currents - Category: Neurology Tags: Epilepsy Curr Source Type: research
Publication date: Available online 14 October 2019Source: NeuroImage: ClinicalAuthor(s): Robert Loughnan, Diego L. Lorca-Puls, Andrea Gajardo-Vidal, Valeria Espejo-Videla, Céline R. Gillebert, Dante Mantini, Cathy J. Price, Thomas M.H. HopeAbstractAround a third of stroke survivors suffer from acquired language disorders (aphasia), but current medicine cannot predict whether or when they might recover. Prognostic research in this area increasingly draws on datasets associating structural brain imaging data with outcome scores for ever-larger samples of stroke patients. The aim is to learn brain-behavior trends from ...
Source: NeuroImage: Clinical - Category: Radiology Source Type: research
Publication date: Available online 14 October 2019Source: Journal of Orthopaedic TranslationAuthor(s): Bing Chen, Bin Zi, Ling Qin, Qiaosheng PanAbstractAgeing population is now a global challenge, where physical deterioration is the common feature in elderly people. In addition, the diseases, such as spinal cord injury, stroke, and injury, could cause a partial or total loss of the ability of human locomotion. Thus, assistance is necessary for them to perform safe activities of daily living. Robotic hip exoskeletons are able to support ambulatory functions in elderly people and provide rehabilitation for the patients with...
Source: Journal of Orthopaedic Translation - Category: Orthopaedics Source Type: research
When the Trump administration dropped the drug rebate rule it introduced back in January, the decision sent shockwaves through the healthcare industry. However, almost everyone engaging in this debate is failing to see one very important thing.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news
ConclusionUniversal OpSalp during hysterectomy, BTL and elective surgery will significantly reduce OvCa mortality and reduce overall healthcare expenditures due to prevention of OvCa. Therefore, it would be reasonable to perform OpSalp in all women undergoing elective surgery.
Source: Journal of Minimally Invasive Gynecology - Category: OBGYN Source Type: research
Publication date: Available online 14 October 2019Source: European Journal of Obstetrics &Gynecology and Reproductive BiologyAuthor(s): Marjan Torabi, Ashraf Kazem, Mahshid AbdishahshahaniAbstractObjectiveThe aim of this study is to validate the edited version of FAS for the purpose of couples undergoing ART.Study designIn this cross-sectional study, the validity of the revised version of the FAS questionnaire was assessed by testing it on 212 couples volunteered to undergo ART. The revised version comprises 12 items from the original FAS version and 6 items added based on a survey interview conducted on infertile coup...
Source: European Journal of Obstetrics and Gynecology and Reproductive Biology - Category: OBGYN Source Type: research
Last month, House Speaker Nancy Pelosi unveiled aradical drug pricing plan, H.R. 3, that could jeopardize the development of innovative treatments for some of the most challenging diseases and leave U.S. patients behind. For example,researchers are focused every day on finding new treatments and cures for amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig ’s Disease), but Pelosi’s plan could threaten future treatments for ALS by imposing government-set prices on critical medicines, creating increased uncertainty and eroding incentives for investment into risky research and development (R&D).
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: Research and Development ALS Source Type: news
Conclusions Frequent adverse events and hospitalizations are of ongoing concern for LVAD recipients. More data are necessary to understand why urban LVAD recipients may experience shorter survival time compared with rural counterparts. Hospitalization may serve as a protective factor for rural LVAD recipients.
Source: Journal of Cardiovascular Nursing - Category: Nursing Tags: ARTICLES: Heart Failure Source Type: research
Conclusions The assessment of MS in HF patient-caregiver dyads is important to formulate interventions aimed at improving anxiety and depression in patients and caregivers.
Source: Journal of Cardiovascular Nursing - Category: Nursing Tags: ARTICLES: Heart Failure Source Type: research
More News: Adenoviruses | ADHD | ALS | Biology | Biomedical Science | Biotechnology | Brain | Brain Cancers | Cancer & Oncology | Child Development | Depression | Dyskinesia | Epilepsy | Food and Drug Administration (FDA) | Funding | Gene Therapy | Genetics | Headache | Hyperactivity | Ischemic Stroke | Migraine | Molecular Biology | Muscular Dystrophy | Neurology | Neuroscience | Postnatal Depression | Reflex Sympathetic Dystrophy | Science | Spinal Cord Injury | Spinal Muscular Atrophy | Stroke | Toxicology | USA Health | Venture Capital